Investor profile
i&i Biotech Fund has backed 6 European tech companies across 6 funding rounds between 2022 and 2026, joining rounds totalling €35M. Most active in Healthtech and AI. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Enzyre | Netherlands | 1 | €12M |
| Antiverse | UK | 1 | €8.0M |
| Delta Diagnostics | Netherlands | 1 | €5.3M |
| HeartBeat.bio | Austria | 1 | €4.5M |
| Ternary Therapeutics | UK |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Enzyre | Series A | €12M | 2022-11 |
| Antiverse | Series A | €8.0M | 2026-03 |
| Delta Diagnostics | Series A | €5.3M | 2023-05 |
| HeartBeat.bio |
| 1 |
| €4.2M |
| CasInvent | Czech Republic | 1 | €1.3M |
| Seed |
| €4.5M |
| 2023-11 |
| Ternary Therapeutics | Seed | €4.2M | 2026-03 |
| CasInvent | Other | €1.3M | 2022-09 |
